Ilham Youssry

784 total citations
47 papers, 528 citations indexed

About

Ilham Youssry is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ilham Youssry has authored 47 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 23 papers in Hematology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ilham Youssry's work include Hemoglobinopathies and Related Disorders (27 papers), Iron Metabolism and Disorders (16 papers) and Prenatal Screening and Diagnostics (6 papers). Ilham Youssry is often cited by papers focused on Hemoglobinopathies and Related Disorders (27 papers), Iron Metabolism and Disorders (16 papers) and Prenatal Screening and Diagnostics (6 papers). Ilham Youssry collaborates with scholars based in Egypt, Lebanon and United States. Ilham Youssry's co-authors include Amal El‐Beshlawy, Alì Taher, Mona Hamdy, Samar Ahmed, Mona Hafez, Olfat Shaker, Elie Aoun, Ramzi El Accaoui, Elhadi Miskeen and Sherine M. Rizk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ilham Youssry

42 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilham Youssry Egypt 13 305 253 91 90 82 47 528
Alex George United States 14 313 1.0× 247 1.0× 195 2.1× 171 1.9× 84 1.0× 34 681
Pustika Amalia Wahidiyat Indonesia 10 295 1.0× 245 1.0× 33 0.4× 79 0.9× 78 1.0× 40 398
Fatma Soliman Elsayed Ebeid Egypt 11 168 0.6× 140 0.6× 25 0.3× 38 0.4× 51 0.6× 58 347
Muhammad Saboor Saudi Arabia 11 80 0.3× 148 0.6× 59 0.6× 68 0.8× 28 0.3× 51 355
Carla Luana Dinardo Brazil 13 151 0.5× 244 1.0× 148 1.6× 35 0.4× 23 0.3× 64 470
Aziz Eghbali Iran 11 138 0.5× 178 0.7× 25 0.3× 39 0.4× 80 1.0× 57 337
Vasili Berdoukas United States 11 384 1.3× 369 1.5× 32 0.4× 22 0.2× 81 1.0× 14 520
Alireza Moafi Iran 13 72 0.2× 106 0.4× 41 0.5× 94 1.0× 109 1.3× 49 400
Stacy Endres‐Dighe United States 10 146 0.5× 161 0.6× 180 2.0× 59 0.7× 73 0.9× 19 427
Mohamed El‐Shanshory Egypt 11 106 0.3× 99 0.4× 19 0.2× 73 0.8× 54 0.7× 41 399

Countries citing papers authored by Ilham Youssry

Since Specialization
Citations

This map shows the geographic impact of Ilham Youssry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilham Youssry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilham Youssry more than expected).

Fields of papers citing papers by Ilham Youssry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilham Youssry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilham Youssry. The network helps show where Ilham Youssry may publish in the future.

Co-authorship network of co-authors of Ilham Youssry

This figure shows the co-authorship network connecting the top 25 collaborators of Ilham Youssry. A scholar is included among the top collaborators of Ilham Youssry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilham Youssry. Ilham Youssry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Mokhtar, Galila M., Ahmed M. Youssef, Ilham Youssry, et al.. (2023). Evidence-based Egyptian clinical practice guidelines: for the prevention and management of iron deficiency and iron deficiency anemia in infants, children and adolescents. SHILAP Revista de lepidopterología. 47(1). 1 indexed citations
4.
Youssry, Ilham, et al.. (2023). The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients. Pediatric Research. 95(4). 1095–1100. 7 indexed citations
5.
Youssry, Ilham, et al.. (2023). COVID-19 Lockdown aggravated the Health-Related Quality of Life in Children with Transfusion-Dependent-Thalassemia. SHILAP Revista de lepidopterología. 0(0). 0–0. 2 indexed citations
6.
Khorshied, Mervat M., et al.. (2022). IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022037–e2022037. 4 indexed citations
7.
Farid, Samar, et al.. (2021). The potential hepatoprotective effect of metformin in hepatitis C virus‐infected adolescent patients with beta thalassemia major: Randomised clinical trial. International Journal of Clinical Practice. 75(6). e14104–e14104. 12 indexed citations
8.
Miskeen, Elhadi, et al.. (2021). Premenstrual Syndrome and Its Impact on the Quality of Life of Female Medical Students at Bisha University, Saudi Arabia. Journal of Multidisciplinary Healthcare. Volume 14. 2373–2379. 25 indexed citations
9.
Youssry, Ilham, et al.. (2021). Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt. International Journal of Hematology. 115(3). 399–405. 3 indexed citations
10.
Gabr, Hala, et al.. (2017). Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome. Transplant Immunology. 45. 53–58. 7 indexed citations
11.
Abd‐Elmawla, Mai A., Sherine M. Rizk, Ilham Youssry, & Amira A. Shaheen. (2016). Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients. PLoS ONE. 11(5). e0155070–e0155070. 12 indexed citations
12.
Youssry, Ilham, et al.. (2015). Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Pediatric Nephrology. 30(12). 2163–2168. 13 indexed citations
13.
El‐Beshlawy, Amal & Ilham Youssry. (2009). Prevention of Hemoglobinopathies in Egypt. Hemoglobin. 33(sup1). S14–S20. 70 indexed citations
14.
El‐Beshlawy, Amal, et al.. (2008). Correction of Aberrant Pre-mRNA Splicing by Antisense Oligonucleotides in β-Thalassemia Egyptian Patients With IVSI-110 Mutation. Journal of Pediatric Hematology/Oncology. 30(4). 281–284. 14 indexed citations
15.
El‐Beshlawy, Amal, et al.. (2008). PULMONARY HYPERTENSION IN β-THALASSEMIA MAJOR AND THE ROLE OF L-CARNITINE THERAPY. Pediatric Hematology and Oncology. 25(8). 734–743. 25 indexed citations
16.
El‐Beshlawy, Amal, Ilham Youssry, Mona Hamdy, et al.. (2008). Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience. Annals of Hematology. 87(7). 545–550. 41 indexed citations
17.
Youssry, Ilham, et al.. (2007). Skin Iron Concentration: a Simple, Highly Sensitive Method for Iron Stores Evaluation in Thalassemia Patients. Hemoglobin. 31(3). 357–365. 11 indexed citations
18.
El‐Beshlawy, Amal, et al.. (2006). Effect of L-carnitine on the physical fitness of thalassemic patients. Annals of Hematology. 86(1). 31–34. 15 indexed citations
19.
El‐Beshlawy, Amal, et al.. (2005). Apoptosis in Thalassemia major Reduced by a Butyrate Derivative. Acta Haematologica. 114(3). 155–159. 11 indexed citations
20.
El‐Beshlawy, Amal, Ilham Youssry, Mona Hamdy, et al.. (2004). Improvement of Cardiac Function in Thalassemia major Treated with <i>L</i>-Carnitine. Acta Haematologica. 111(3). 143–148. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex George Breakdown of academic impact, for papers by Pustika Amalia Wahidiyat Breakdown of academic impact, for papers by Fatma Soliman Elsayed Ebeid Breakdown of academic impact, for papers by Muhammad Saboor Breakdown of academic impact, for papers by Carla Luana Dinardo Breakdown of academic impact, for papers by Aziz Eghbali Breakdown of academic impact, for papers by Vasili Berdoukas Breakdown of academic impact, for papers by Alireza Moafi Breakdown of academic impact, for papers by Stacy Endres‐Dighe Breakdown of academic impact, for papers by Mohamed El‐Shanshory
Rankless by CCL
2026